Powder: -20°C for 3 years | In solvent: -80°C for 1 year
L 012 sodium salt 是一种 luminol 类似物,是一种广泛使用的活性氧和活性氮的化学发光(CL)探针 的化学发光 (CL) 探针。L 012 sodium salt 广泛用于检测 NADPH 氧化酶 (Nox) 衍生的超氧化物 (O2•−) ,用于发现 Nox 抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 333 | 现货 | ||
5 mg | ¥ 793 | 现货 | ||
10 mg | ¥ 1,310 | 现货 | ||
25 mg | ¥ 2,250 | 现货 | ||
50 mg | ¥ 3,350 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 877 | 现货 |
产品描述 | L 012 sodium salt, a luminol analogue, is a widely used chemiluminescent (CL) probe for active oxygen and active nitrogen. L 012 sodium salt is widely used to detect the superoxides (O2•−) derived from NADPH oxidase (Nox) to find Nox inhibitors. |
体外活性 | L 012 sodium salt is a new chemiluminescent probe. In activated EoL-1 cells which generated reactive oxygen species (ROS), treatment with L-012 generated a significant chemiluminescence. While, superoxide dismutase (100-300 U/ml) abolished the chemiluminescence, which suggested that the main ROS detected was O2- [1]. In cultured endothelial cells, phorbol 12-myristate 13-acetate (PMA, 1 μM) caused an 2.8-fold increase of L-012 chemiluminescence. Vanadate (100 μM) increased the chemiluminescence up to 17-fold. These results suggested that the increase of superoxide produced by NAD(P)H oxidase |
体内活性 |
In the human oral cavity and blood and rat peritoneal cavity, L-012 reacted with ROS generated by activated neutrophils and generated strong chemiluminescence, which was higher than that of MCLA [2].
In nonobese diabetic mice and K8 knockout (K8(-/-)) mice, treatment with dextran sulfate sodium generated an increased L-012 chemiluminescence which detected reactive oxygen and nitrogen species (ROS and RNS) [3]. |
分子量 | 310.67 |
分子式 | C13H8ClN4NaO2 |
CAS No. | 143556-24-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 3.0 mg/mL (9.6 mM), Sonication and heating to 60℃ are recommended.
DMSO: 45.0 mg/mL (144.8 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.2188 mL | 16.0942 mL | 32.1885 mL | 80.4712 mL |
5 mM | 0.6438 mL | 3.2188 mL | 6.4377 mL | 16.0942 mL | |
DMSO | 10 mM | 0.3219 mL | 1.6094 mL | 3.2188 mL | 8.0471 mL |
20 mM | 0.1609 mL | 0.8047 mL | 1.6094 mL | 4.0236 mL | |
50 mM | 0.0644 mL | 0.3219 mL | 0.6438 mL | 1.6094 mL | |
100 mM | 0.0322 mL | 0.1609 mL | 0.3219 mL | 0.8047 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
L 012 sodium salt 143556-24-5 L 012 sodium Inhibitor inhibitor inhibit